Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy.

J Clin Med · 2022 · PMC8836680 · PMID 35159947

Europe PMC DOI

hedged sentence

0.3910

closest p · 7.8× alpha

0.3910

boldest claim

The sentences

showed a trendp = 0.391not close (p > 0.1)

In the present study, we analysed CD36 by IHC in TMAs from tumour specimens obtained during cystectomy and found that CD36 immunopositivity was significantly associated with greater depth of tumour invasion (pT3b-pT4 stage) and showed a trend toward association with greater lymph node involvement (pN stage) ( p = 0.391), both of which are well-known markers of poor prognosis in MIBC [ 38 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.